Trial
NCT06297642
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Advanced Malignant Neoplasm
Intervention
TQB2928 injection
Why stopped
Based on the current status of the same target research and the company's overall layout in the field of tumors, the early termination was determined after full communication with the principal investigator of the group leader unit.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-06